Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001731122-22-001013
Filing Date
2022-05-27
Accepted
2022-05-27 20:30:22
Documents
1
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6869
  Complete submission text file 0001731122-22-001013.txt   8315
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 14,RUE KLEBERG GENEVA V8 CH-1201
Business Address
Skarpelos Athanasios (Reporting) CIK: 0001360570 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37606 | Film No.: 22980045